Growth performance in anemia and following iron supplementation

Area of Science:

• Pediatric Nutrition
• Hematology
• Child Growth and Development

Background:

• Anemia is a prevalent condition in young children, particularly in developing regions.
• Poor nutritional status and iron deficiency are common causes of anemia in children.
• Anemia can negatively impact a child's overall growth and development.

Purpose of the Study:

• To evaluate the growth status of anemic children compared to normal children.
• To assess the effect of iron supplementation on hemoglobin levels and growth parameters in anemic children.

Main Methods:

• Cross-sectional study comparing growth parameters (weight, height, weight-for-age, weight-for-height) between anemic and normal children aged 3-5 years.
• Dietary intake was assessed in a subsample.
• A randomized controlled trial of iron supplementation (40 mg elemental iron/day for six months) was conducted in anemic children, with a placebo group.

Main Results:

• Anemic children exhibited significantly poorer growth status, including lower body weight, height, and weight-for-age, and a higher prevalence of malnutrition (Grades II and III).
• Iron supplementation led to a significant increase in hemoglobin levels in both anemic and non-anemic children compared to placebo.
• Anemic children receiving iron supplements showed superior growth performance, evidenced by better weight gain and significantly higher weight-for-height compared to anemic children on placebo.

Conclusions:

• Anemia is associated with impaired growth in young children.
• Iron supplementation is effective in improving hemoglobin levels and promoting better growth outcomes in anemic children.
• Weight-for-age effectively differentiates anemic from normal children, while weight-for-height indicates the impact of iron supplementation on growth.